The post-pandemic landscape provides great opportunities for the Life Sciences industry, which comprehends all organizations dedicated to the pharmaceutical industry, health care, biotechnology and their sub-sectors.
The pandemic was a catalyst in the generation of innovative solutions in science and technology. These responses provided by all sectors due to the emergency situation caused permanent changes in the way we work, shop and access to servicess. At the same time, consumer expectations regarding the sustainability and agility in the supply chain increased.
Today, it is clear that people expect greater flexibility, inclusion, and purpose from the organizations they work for. At Grant Thornton, we understand the commitment and need to comply with prevailing industry regulations, which is why we work closely with clients to respond to these challenges.
By working with clients who carry out a wide range of activities within the Life Sciences industry, we have a broad understanding of the specific challenges these organizations face.
Our teams are passionate about helping clients achieve their mission and objectives, offering innovative solutions that allow them to develop new skills and open sources of financing.
The commercial relationship between Argentina and the United Kingdom began in Argentina's early days. In 1810 the British Commercial Rooms was founded, which in 1914 gave way to BritCham, the Argentine-British Chamber of Commerce in Argentina. During the first half of the 19th century, Argentina was the United Kingdom's main trading partner in Latin America.
Germany and Argentina have more than 160 years of binational relations based not only on political issues, but also social and economic. Both countries are great trading partners.
Although Austria mainly trades with member countries of the European Union, Argentina occupies fourth place in Austrian consumer markets in Latin America.
